The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

According to The Business Research Company’s Biomarkers Global Market Report 2023, the biomarkers market is expected to show promising growth in the forecast period.

The global biomarkers market is on an upward trajectory, with the market size set to surge from $54.4 billion in 2022 to $61.72 billion in 2023, reflecting a compelling compound annual growth rate (CAGR) of 13.4%. This growth trend is anticipated to continue, reaching $104.85 billion in 2027, driven by a robust CAGR of 14.2%. Let’s delve into the key factors shaping this evolution, with a specific focus on the role of biomarkers in addressing the rise in heart diseases.

Heart Diseases Surge: A Driving Force

• Biomarkers in Heart Disease: The use of biomarkers, particularly natriuretic peptides, has witnessed a significant surge in heart disease diagnosis.
• Diagnostic Tools: Circulating biomarkers like high-sensitivity C-reactive protein play a crucial role in heart failure diagnosis.
• Alarming Statistics: Heart disease stands among the leading causes of death globally, with a substantial increase reported in recent years.
• US Statistics: In 2020, heart disease deaths in the US increased by 4.8%, marking the largest surge since 2012.
• Growing Demand: The surge in heart diseases is expected to drive the demand for biomarkers, addressing the critical need for early detection and management.

Key Players Paving the Way

• Industry Leaders: Enzo Biochem Inc., Bio-Rad Laboratories Inc., F Hoffmann-La Roche Ltd., and Thermo Fisher Scientific Inc. are major players shaping the biomarkers market.
• Global Presence: Players like Abbott, Siemens, and QIAGEN contribute to the market’s global presence.
• Diverse Offerings: Companies such as GE Healthcare and EKF Diagnostics Holdings plc provide a range of solutions, reinforcing their positions in the market.

Trend Spotlight: Rise in Agreements

• Strategic Agreements: A key trend in the biomarkers market involves major players forming agreements to enhance their offerings and market standing.
• Case Study: Thermo Fisher Scientific’s CDx agreement with Chugai Pharmaceutical in July 2020 aimed at expanding the use of diagnostic tests for non-small cell lung cancer in Japan.
• Collaborative Initiatives: Thermo Fisher Scientific’s collaboration with AstraZeneca and the University of Nebraska Medical Center in September 2020 focuses on standardizing workflows for biomarker research.

Market Segmentation: Diverse Dimensions

• Technology Landscape: Safety Biomarkers, Efficacy Biomarkers, and Validation Biomarkers are pivotal technologies in biomarker development.
• Disease Focus: Biomarkers find applications in Neurological Diseases, Cancer, Immunological Diseases, Cardiovascular Diseases, and other health challenges.
• Type Varieties: Biomarkers are categorized as Biomarkers of Exposure and Biomarkers of Diseases.
• Audience Engagement: Pharmaceutical Companies, Government and Private Research Institutes, Academic Institutes, and Medical Device Manufacturing Companies are key stakeholders.
• Application Spectrum: Biomarkers play a crucial role in Risk Assessment, Molecular Diagnostic Development, Disease Diagnosis, Drug Discovery and Development, Drug Formulation, Forensic Applications, and more.

Regional Dynamics: North America Leading, Asia-Pacific Rising

• Current Leader: North America held the largest share in the biomarkers market in 2022.
• Emerging Hub: Asia-Pacific is anticipated to be the fastest-growing region in the forecast period, indicating a shift in market dynamics.

View More On The Biomarkers Market Report 2023 – https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report

Request A Sample Of The Global Biomarkers Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=6485&type=smp

The Biomarkers Global Market Report 2023  offers a comprehensive overview on the biomarkers market size, growth rate, trends and drivers, opportunities, strategies, and competitor landscape. The countries covered in the biomarkers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The Table Of Content For The Biomarkers Market Include:
1. Biomarkers Market Executive Summary
2. Biomarkers Market Segments
3. Biomarkers Market Size And Biomarkers Market Growth Rate
4. Key Biomarkers Market Trends
5. Major Biomarkers Market Drivers
……
25. Key Mergers And Acquisitions In The Biomarkers Market
26. Top Biomarkers Companies
27. Biomarkers Market Opportunities And Strategies
28. Biomarkers Market, Conclusions And Recommendations
29. Appendix

View More Related Reports –
Renal Biomarkers Global Market Report 2023
Non-Alcoholic Steatohepatitis Biomarkers Global Market Report 2023
Cardiac Biomarkers Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model